Glioblastoma Spheroid Invasion through Soft, Brain-Like Matrices Depends on Hyaluronic Acid-CD44 Interactions
Autor: | Gevick Safarians, Alireza Sohrabi, Itay Solomon, Weikun Xiao, Soniya Bastola, Bushra W. Rajput, Mary Epperson, Isabella Rosenzweig, Kelly Tamura, Breahna Singer, Joyce Huang, Mollie J. Harrison, Talia Sanazzaro, Michael C. Condro, Harley I. Kornblum, Stephanie K. Seidlits |
---|---|
Rok vydání: | 2023 |
Předmět: |
Tumor
Medical Biotechnology glioblastoma Neurosciences Biomedical Engineering Pharmaceutical Science Brain Article Cell Line ezrin Brain Disorders Biomaterials Brain Cancer Medicinal and Biomolecular Chemistry Hyaluronan Receptors Rare Diseases Cell Movement Clinical Research Humans Hyaluronic Acid CD44 hyaluronic acids hydrogels Cancer |
Zdroj: | Advanced healthcare materials, vol 12, iss 14 Adv Healthc Mater |
Popis: | Increased secretion of hyaluronic acid (HA), a glycosaminoglycan abundant in the brain extracellular matrix (ECM), correlates with worse clinical outcomes for glioblastoma (GBM) patients. GBM cells aggressively invade the brain parenchyma while encountering spatiotemporal changes in their local ECM, including HA concentration. To investigate how varying HA concentrations affect GBM invasion, we cultured patient-derived GBM cells within a soft, three-dimensional matrix in which HA concentration was precisely varied and cell migration observed. Data demonstrate that HA concentration can determine the invasive activity of patient-derived GBM cells in a biphasic and highly sensitive manner, where the absolute concentration of HA at which cell migration peaked was specific to each patient-derived line. Furthermore, we provide evidence that this response relies on phosphorylated ezrin, which interacts with the intracellular domain of HA-engaged CD44 to effectively link the actin cytoskeleton to the local ECM. Overall, this study highlights CD44-HA binding as a major mediator of GBM cell migration that acts independently of integrins and focal adhesion complexes and suggests that targeting HA-CD44-ezrin interactions represents a promising therapeutic strategy to prevent tumor cell invasion in the brain. |
Databáze: | OpenAIRE |
Externí odkaz: |